Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofov...
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1
About this item
Full title
Author / Creator
NEAT 001/ ANRS 143 Study Group , Stella-Ascariz, Natalia , Montejano, Rocio , Rodriguez-Centeno, Javier , Alejos, Belen , Schwimmer, Christine , Bernardino, Jose I , Rodes, Berta , Allavena, Clotilde , Hoffmann, Christian , Gisslén, Magnus , de Miguel, Rosa , Esteban-Cantos, Andrés , Wallet, Cédrick , Raffi, François and Arribas, Jose R
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Tenofovir is a potent inhibitor of human telomerase. The clinical relevance of this inhibition is unknown.
NEAT001/ANRS143 is a randomized trial that showed noninferiority over 96 weeks of ritonavir-boosted darunavir plus raltegravir versus tenofovir disoproxil fumarate/emtricitabine in 805 antiretroviral antiretrovrial-naive HIV-infected adults...
Alternative Titles
Full title
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1
Authors, Artists and Contributors
Author / Creator
Stella-Ascariz, Natalia
Montejano, Rocio
Rodriguez-Centeno, Javier
Alejos, Belen
Schwimmer, Christine
Bernardino, Jose I
Rodes, Berta
Allavena, Clotilde
Hoffmann, Christian
Gisslén, Magnus
de Miguel, Rosa
Esteban-Cantos, Andrés
Wallet, Cédrick
Raffi, François
Arribas, Jose R
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_gup_ub_gu_se_273196
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_273196
Other Identifiers
ISSN
0022-1899,1537-6613
E-ISSN
1537-6613
DOI
10.1093/infdis/jiy399
